FLT3LG as an inflammatory hub bridging tumor immune surveillance to therapy response in breast cancer

Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209–49.

PubMed  Google Scholar 

de Visser KE, Joyce JA. The evolving tumor microenvironment: from cancer initiation to metastatic outgrowth. Cancer Cell. 2023;41:374–403.

Article  PubMed  Google Scholar 

Brasel K, De Smedt T, Smith JL, Maliszewski CR. Generation of murine dendritic cells from flt3-ligand-supplemented bone marrow cultures. Blood. 2000;96:3029–39.

Article  CAS  PubMed  Google Scholar 

McKenna HJ, Stocking KL, Miller RE, Brasel K, De Smedt T, Maraskovsky E, et al. Mice lacking flt3 ligand have deficient hematopoiesis affecting hematopoietic progenitor cells, dendritic cells, and natural killer cells. Blood. 2000;95:3489–97.

Article  CAS  PubMed  Google Scholar 

Barry KC, Hsu J, Broz ML, Cueto FJ, Binnewies M, Combes AJ, et al. A natural killer-dendritic cell axis defines checkpoint therapy-responsive tumor microenvironments. Nat Med. 2018;24:1178–91.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li S, Zhang N, Zhang H, Yang Z, Cheng Q, Wei K, et al. Deciphering the role of LGALS2: insights into tertiary lymphoid structure-associated dendritic cell activation and immunotherapeutic potential in breast cancer patients. Mol Cancer. 2024;23:216.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhang N, Zhang H, Li S, Wu W, Luo P, Liu Z, et al. Uncovering the predictive and immunomodulatory potential of transient receptor potential melastatin family-related CCNE1 in pan-cancer. Mol Cancer. 2024;23:258.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hla DA, Hindin DI. Generative AI & machine learning in surgical education. Curr Probl Surg. 2025;63:101701.

Article  PubMed  Google Scholar 

Skov RAC, Lawaetz J, Strom M, Van Herzeele I, Konge L, Resch TA, et al. Machine learning enhances assessment of proficiency in endovascular aortic repair simulations. Curr Probl Surg. 2024;61:101576.

Article  PubMed  Google Scholar 

Zhang H, Lin C, Chen Y, Shen X, Wang R, Chen Y, et al. Enhancing molecular network-based cancer driver gene prediction using machine learning approaches: current challenges and opportunities. J Cell Mol Med. 2025;29:e70351.

Article  PubMed  PubMed Central  Google Scholar 

Morabito S, Reese F, Rahimzadeh N, Miyoshi E, Swarup V. Hdwgcna identifies co-expression networks in high-dimensional transcriptomics data. Cell Rep Methods. 2023;3:100498.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Papanicolaou M, Parker AL, Yam M, Filipe EC, Wu SZ, Chitty JL, et al. Temporal profiling of the breast tumour microenvironment reveals collagen XII as a driver of metastasis. Nat Commun. 2022;13:4587.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Satija R, Farrell JA, Gennert D, Schier AF, Regev A. Spatial reconstruction of single-cell gene expression data. Nat Biotechnol. 2015;33:495–502.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Korsunsky I, Millard N, Fan J, Slowikowski K, Zhang F, Wei K, et al. Fast, sensitive and accurate integration of single-cell data with harmony. Nat Methods. 2019;16:1289–96.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Barbie DA, Tamayo P, Boehm JS, Kim SY, Moody SE, Dunn IF, et al. Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1. Nature. 2009;462:108–12.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dalal H, Dahlgren M, Gladchuk S, Brueffer C, Gruvberger-Saal SK, Saal LH. Clinical associations of ESR2 (estrogen receptor beta) expression across thousands of primary breast tumors. Sci Rep. 2022;12:4696.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jezequel P, Kerdraon O, Hondermarck H, Guerin-Charbonnel C, Lasla H, Gouraud W, et al. Identification of three subtypes of triple-negative breast cancer with potential therapeutic implications. Breast Cancer Res. 2019;21:65.

Article  PubMed  PubMed Central  Google Scholar 

Liberzon A, Birger C, Thorvaldsdottir H, Ghandi M, Mesirov JP, Tamayo P. The molecular signatures database (MSigDB) hallmark gene set collection. Cell Syst. 2015;1:417–25.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Aibar S, Gonzalez-Blas CB, Moerman T, Huynh-Thu VA, Imrichova H, Hulselmans G, et al. SCENIC: single-cell regulatory network inference and clustering. Nat Methods. 2017;14:1083–6.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ishwaran H, Kogalur UB, Blackstone EH, Lauer MS. Random survival forests. Ann Appl Stat. 2008;2:841–60.

Article  Google Scholar 

De Bin R. Boosting in Cox regression: a comparison between the likelihood-based and the model-based approaches with focus on the R-packages CoxBoost and mboost. Comput Stat. 2016;31:513–31.

Article  Google Scholar 

Maeser D, Gruener RF, Huang RS. oncoPredict: an R package for predicting in vivo or cancer patient drug response and biomarkers from cell line screening data. Brief Bioinform. 2021. https://doi.org/10.1093/bib/bbab260.

Article  PubMed  PubMed Central  Google Scholar 

Becht E, Giraldo NA, Lacroix L, Buttard B, Elarouci N, Petitprez F, et al. Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression. Genome Biol. 2016;17:218.

Article  PubMed  PubMed Central  Google Scholar 

Charoentong P, Finotello F, Angelova M, Mayer C, Efremova M, Rieder D, et al. Pan-cancer immunogenomic analyses reveal genotype-immunophenotype relationships and predictors of response to checkpoint blockade. Cell Rep. 2017;18:248–62.

Article  CAS  PubMed  Google Scholar 

Davoli T, Uno H, Wooten EC, Elledge SJ. Tumor aneuploidy correlates with markers of immune evasion and with reduced response to immunotherapy. Science. 2017. https://doi.org/10.1126/science.aaf8399.

Article  PubMed  PubMed Central  Google Scholar 

Thorsson V, Gibbs DL, Brown SD, Wolf D, Bortone DS, Ou Yang TH, et al. The immune landscape of cancer. Immunity. 2018;48:812–30.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhang N, Yang M, Yang JM, Zhang CY, Guo AY. A predictive network-based immune checkpoint blockade immunotherapeutic signature optimizing patient selection and treatment strategies. Small Methods. 2024;8:e2301685.

Article  PubMed  Google Scholar 

Rooney MS, Shukla SA, Wu CJ, Getz G, Hacohen N. Molecular and genetic properties of tumors associated with local immune cytolytic activity. Cell. 2015;160:48–61.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ayers M, Lunceford J, Nebozhyn M, Murphy E, Loboda A, Kaufman DR, et al

Comments (0)

No login
gif